Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę
Tytuł pozycji:

Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.

Tytuł :
Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.
Autorzy :
Raimond VC; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital.; Harvard Medical School.
Feldman WB; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital.; Harvard Medical School.; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital.
Rome BN; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital.; Harvard Medical School.
Kesselheim AS; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital.; Harvard Medical School.
Pokaż więcej
Źródło :
The Milbank quarterly [Milbank Q] 2021 Mar; Vol. 99 (1), pp. 240-272.
Typ publikacji :
Comparative Study; Journal Article
Język :
English
Imprint Name(s) :
Publication: Malden, MA : New York, NY : Blackwell Publishers ; Milbank Memorial Fund
Original Publication: New York, NY : Published for the Milbank Memorial Fund by Cambridge University Press, c1986-
MeSH Terms :
Cost Savings*
Government Regulation*
Medicare Part D/*economics
Prescription Drugs/*economics
Costs and Cost Analysis ; Drug Costs/legislation & jurisprudence ; France ; Insurance Coverage ; Legislation, Drug ; United States
References :
J Mark Access Health Policy. 2017 Mar 29;5(1):1297886. (PMID: 28473887)
Int J Health Plann Manage. 2005 Oct-Dec;20(4):307-28. (PMID: 16335080)
J Mark Access Health Policy. 2016 May 10;4:. (PMID: 27226845)
JAMA Intern Med. 2017 Aug 1;177(8):1185-1188. (PMID: 28558108)
PLoS Med. 2019 Jul 30;16(7):e1002872. (PMID: 31361747)
Health Policy. 2008 Mar;85(3):305-13. (PMID: 17928092)
JAMA. 2020 Mar 3;323(9):854-862. (PMID: 32125403)
Orphanet J Rare Dis. 2017 Apr 21;12(1):75. (PMID: 28427466)
JAMA. 2019 Jul 16;322(3):267-269. (PMID: 31310287)
Health Aff (Millwood). 2018 May;37(5):738-742. (PMID: 29733710)
JAMA Intern Med. 2020 Apr 1;180(4):601. (PMID: 32011621)
Health Aff (Millwood). 2003 Jul-Aug;22(4):220-9. (PMID: 12889771)
JAMA. 2020 Jul 28;324(4):399. (PMID: 32720997)
Expert Rev Pharmacoecon Outcomes Res. 2018 Feb;18(1):71-81. (PMID: 28800399)
N Engl J Med. 2017 Dec 28;377(26):2597-2598. (PMID: 29281576)
JAMA. 2018 Mar 13;319(10):1024-1039. (PMID: 29536101)
Expert Rev Pharmacoecon Outcomes Res. 2017 Apr;17(2):221-230. (PMID: 27658050)
Am J Med. 2019 Sep;132(9):1013-1016. (PMID: 31034803)
Contributed Indexing :
Keywords: France*; Medicare*; Prescription drug prices*; United States*; drug regulation*
Substance Nomenclature :
0 (Prescription Drugs)
Entry Date(s) :
Date Created: 20210322 Date Completed: 20210407 Latest Revision: 20210407
Update Code :
20210623
PubMed Central ID :
PMC7984670
DOI :
10.1111/1468-0009.12507
PMID :
33751664
Czasopismo naukowe
Policy Points  Spending on prescription drugs is much higher per capita in the United States than in most other industrialized nations, including France.  Lower prescription drug spending in France is due to different approaches to managing drug prices, volume of prescribing, and global health budgets.  Linking a drug's price to value both at the launch of the drug and over its lifetime is key to controlling spending. Regulations on prescription volume and global spending complement the interventions on prices.  If the United States adopted the French approach to regulating drug pricing, Medicare could potentially save billions of dollars annually on prescription drug spending.
Context: Prescription drug spending per capita in the United States is higher than in most other industrialized countries. Policymakers seeking to lower drug spending often suggest benchmarking prices against other countries, including France, which spends half as much as the United States per capita on prescription drugs. Because differences in drug prices may result from how markets are organized in each nation, we sought to directly compare drug prices and pricing regulations between the United States and France.
Methods: For the six brand-name drugs with the highest gross expenditures in Medicare Part D in 2017, we compared the price dynamics in France and the United States between 2010 and 2018 and analyzed associations between price changes in each country and key regulatory events. We also comprehensively reviewed US and French laws and regulations related to drug pricing.
Findings: Prices for the six drugs studied were higher in the United States than in France. In 2018, if Medicare had paid French prices for the brand-name drugs in our cohort, the agency would have saved $5.1 billion. We identified 12 factors that explain why the United States spends more than France on drugs, including variations in unit prices and the volume of prescriptions, driven by use of health technology assessment and value-based pricing in France.
Conclusions: Key drivers of lower drug spending in France compared to the United States are that the French government regulates drug prices when products are launched and prohibits substantial price increases after launch. The regulation of prescription drugs in France is governed by rules that can inform discussions of US prescription drug policy and potential Medicare price negotiations.
(© 2021 Milbank Memorial Fund.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies